1-3 of 3
Jennifer K. Grossman, MD BSc
Close
Sort by
Journal Articles

Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency

Jennifer Cuellar-Rodriguez, MD, Dennis D. Hickstein, MD, Jennifer K. Grossman, MD BSc, Mark Parta, MD, Juan Gea-Banacloche, MD, Christa S. Zerbe, MD, Alexandra F Freeman, MD, Steven M. Holland, MD, Katherine R. Calvo, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 1247.
https://doi.org/10.1182/blood.V124.21.1247.1247
Published: 2014
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency

Jennifer Cuellar-Rodriguez, M.D., Alexandra F Freeman, MD, Juan Gea-Banacloche, MD, Helen Su, MD, PHD, Jennifer K. Grossman, MD, BSc, Terry J Fry, MD, Steven M. Holland, MD, Dennis D. Hickstein, M.D.
Journal: Blood
Blood (2013) 122 (21): 2114.
https://doi.org/10.1182/blood.V122.21.2114.2114
Published: 2013
Journal Articles

Presence of Minimal Residual Disease by Flow Cytometry After Induction Chemotherapy Is Less Predictive of Overall and Progression-Free Survival Compared to Conventional Prognostic Factors Including Cytogenetic Risk and Age

Cameron D. Griffiths, MD, Elena Liew, MD, Jennifer K. Grossman, MD, BSc, Douglas A. Stewart, MD, FRCP, Joanne Luider, Iwona Auer, Adnan Mansoor, MD, FRCPC, Michelle Geddes, MD
Journal: Blood
Blood (2012) 120 (21): 1424.
https://doi.org/10.1182/blood.V120.21.1424.1424
Published: 2012